Together, these results indicate that calcitriol suppresses AKT signaling in HER2-positive breast cancer cells, thereby potentially enhancing the antiproliferative efficacy of antiestrogens and tyrosine kinase inhibitors. The gene discussed is AKT1; the disease is breast carcinoma.